Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinics in Liver Disease|October 7, 2005
HIV and liver diseases: recent clinical advancesCem Cengiz, James S Park, Neeraj Saraf, et al.
Journal of Hepatology|July 15, 2018
Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infectionJohannes Vermehren, James S Park, Ira M Jacobson, et al.
Human Pathology|September 6, 2017
Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical centerMark Ettel, Gabriel Acosta Gonzalez, Shweta Gera, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 27, 2007
Functional polymorphisms of the GSTT-1 gene do not predict the severity of acute pancreatitis in the United StatesYasser M Bhat, Georgios I Papachristou, James S Park, et al.
European Journal of Gastroenterology & Hepatology|November 14, 2006
Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimenStephanie A Santos, Alison J Uriel, James S Park, et al.
Journal of Pharmacy Practice|May 31, 2022
Successful Treatment of Tenofovir Alafenamide-Induced Lactic Acidosis: A Case ReportSerena Arnouk, Maureen Whitsett, John Papadopoulos, et al.
Nanomaterials (Basel, Switzerland)|March 25, 2017
Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular CarcinomaHea Ry Oh, Hyun-Young Jo, James S Park, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 19, 2019
Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular CarcinomaChenyang Zhan, David Ruohoniemi, Krishna P Shanbhogue, et al.
The American Journal of Gastroenterology|May 16, 2021
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic ImplicationsSaamia Faruqui, Fidelis C Okoli, Sonja K Olsen, et al.
Pageof 3